The term ataxia refers to a lack of coordination caused by dysfunction within the nervous system. In dogs affected by Late Onset Ataxia, genetic mutations interfere with the normal function and maintenance of specific nerve cells. As these cells gradually deteriorate, communication between the brain, spinal cord, and muscles becomes impaired. The result is a progressive loss of coordination that can affect daily activities and quality of life.
Clinical signs of LOA usually appear in adult dogs and may initially be subtle. Early symptoms often include mild unsteadiness, difficulty turning, occasional stumbling, or a slightly abnormal gait. As the condition progresses, affected dogs may develop more pronounced balance problems, weakness, swaying while walking, exaggerated limb movements, and difficulty navigating stairs or uneven surfaces. Some dogs may also experience tremors, reduced muscle control, or challenges maintaining a normal posture. Because the disease develops gradually, symptoms may worsen over months or years.
The LOA DNA Health Test is designed to identify the specific genetic mutation associated with Late Onset Ataxia. Testing is simple, safe, and non-invasive, typically requiring either a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine the dog's genetic status. Since DNA remains unchanged throughout life, testing can be performed at any age, including before clinical signs become apparent.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the LOA mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but is typically unaffected by the disease. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Late Onset Ataxia during its lifetime.
Genetic testing for LOA provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the disorder while maintaining healthy genetic diversity within the breed population. Avoiding the breeding of two carrier dogs significantly decreases the risk of producing affected puppies.
For dog owners, understanding a dog's genetic status allows for proactive neurological monitoring and early veterinary intervention. Dogs identified as at risk may benefit from regular neurological examinations, mobility assessments, and supportive care measures designed to maintain comfort and quality of life. While there is currently no cure for the underlying genetic cause of LOA, early diagnosis can help guide management strategies and prepare owners for potential future health challenges.
The Late Onset Ataxia (LOA) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this inherited movement disorder in future generations. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term welfare.
